Abramson Cancer of the University of Pennsylvania at Perelman Center for Advanced Medicine is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
Abramson Cancer of the University of Pennsylvania at Perelman Center for Advanced Medicine has participated in 1 clinical trials.
Therapeutic areas: Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction.
Sponsors: Genta Incorporated.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer of the University of Pennsylvania at Perelman Center for Advanced Medicine has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer of the University of Pennsylvania at Perelman Center for Advanced Medicine has 1 clinical trials on record. Their work covers Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction.
Abramson Cancer of the University of Pennsylvania at Perelman Center for Advanced Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.